Cargando…
Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
Herein, we report the effect of nine FDA approved protease inhibitor drugs against a new HIV-1 subtype C mutant protease, E35D↑G↑S. The mutant has five mutations, E35D, two insertions, position 36 (G and S), and D60E. Kinetics, inhibition constants, vitality, Gibbs free binding energies are reported...
Autores principales: | Maseko, Sibusiso, Padayachee, Eden, Maphumulo, Siyabonga, Govender, Thavendran, Sayed, Yasien, Maguire, Glenn, Lin, Johnson, Naicker, Tricia, Baijnath, Sooraj, Gerhardus, Kruger Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713120/ https://www.ncbi.nlm.nih.gov/pubmed/31409143 http://dx.doi.org/10.1080/14756366.2019.1636234 |
Ejemplares similares
-
A novel and more efficient biosynthesis approach for human insulin production in Escherichia coli (E. coli)
por: Govender, Kamini, et al.
Publicado: (2020) -
Mass Spectrometry
Imaging Demonstrates the Regional
Brain Distribution Patterns of Three First-Line Antiretroviral Drugs
por: Ntshangase, Sphamandla, et al.
Publicado: (2019) -
Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system
por: Pamreddy, Annapurna, et al.
Publicado: (2018) -
Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors
por: Honarparvar, Bahareh, et al.
Publicado: (2013) -
Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study
por: Honarparvar, Bahareh, et al.
Publicado: (2015)